• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂-表柔比星-碘油混悬液治疗肝细胞癌:一项临床药理学初步研究。

Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.

作者信息

Ichida T, Kato M, Hayakawa A, Watanabe M, Igarashi K, Hata K, Doya Y, Miura M, Sato H, Asakura H

机构信息

Third Department of Internal Medicine, Niigata University School of Medicine, Japan.

出版信息

Cancer Chemother Pharmacol. 1992;31 Suppl:S51-4. doi: 10.1007/BF00687105.

DOI:10.1007/BF00687105
PMID:1281045
Abstract

Lipiodol injection is a useful method for detecting liver tumors, especially hepatocellular carcinoma (HCC). We therefore prepared and tested a new emulsion of lipiodol containing epirubicin and cis-diammine-dichloroplatinum (CDDP), drugs that are very effective against HCC. This CDDP-epirubicin-lipiodol suspension (CELS) was injected into 18 HCC patients via a celiac angiographic catheter. In 11 of these patients, CELS was followed by transcatheter arterial embolization (TAE) therapy. Clinical and pharmacological investigations were performed in all 18 patients, and the following results were obtained. CELS is pharmacologically and chemically stable, and both the results of the dissolution test and the serum levels of these two drugs indicate that slow release can be obtained. After the injection of CELS, serum levels of AFP and PIVKA-II decreased immediately, and no fatal clinical side effects were encountered. Although no statistically significant difference was observed, the survival (Kaplan-Meier method) of patients injected with CELS in the presence or absence of TAE therapy can be estimated to be much longer than that of patients receiving CDDP-lipiodol suspension injection in the presence (16 patients) or absence (6 patients) of TAE therapy. A combination of CELS injection and TAE therapy might be effective and useful for the treatment of HCC.

摘要

碘油注射是检测肝脏肿瘤,尤其是肝细胞癌(HCC)的一种有用方法。因此,我们制备并测试了一种含表柔比星和顺二氯二氨铂(CDDP)的新型碘油乳剂,这两种药物对HCC非常有效。将这种顺铂-表柔比星-碘油混悬液(CELS)通过腹腔血管造影导管注入18例HCC患者体内。其中11例患者在注入CELS后接受了经导管动脉栓塞(TAE)治疗。对所有18例患者进行了临床和药理学研究,获得了以下结果。CELS在药理和化学上是稳定的,溶出度试验结果和这两种药物的血清水平均表明可以实现缓释。注入CELS后,甲胎蛋白(AFP)和异常凝血酶原-II(PIVKA-II)的血清水平立即下降,且未出现致命的临床副作用。尽管未观察到统计学上的显著差异,但接受或未接受TAE治疗的注入CELS的患者的生存期(Kaplan-Meier法)估计比接受或未接受TAE治疗(分别为16例和6例)的接受顺铂-碘油混悬液注射的患者长得多。CELS注射与TAE治疗相结合可能对HCC的治疗有效且有用。

相似文献

1
Treatment of hepatocellular carcinoma with a CDDP-epirubicin-lipiodol suspension: a pilot clinico-pharmacological study.顺铂-表柔比星-碘油混悬液治疗肝细胞癌:一项临床药理学初步研究。
Cancer Chemother Pharmacol. 1992;31 Suppl:S51-4. doi: 10.1007/BF00687105.
2
Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.顺铂-表柔比星-碘油乳剂对晚期肝细胞癌的治疗效果
Cancer Chemother Pharmacol. 1994;33 Suppl:S74-8. doi: 10.1007/BF00686672.
3
A phase II trial of transcatheter arterial infusion chemotherapy with an epirubicin-Lipiodol emulsion for advanced hepatocellular carcinoma refractory to transcatheter arterial embolization.一项关于表柔比星-碘油乳剂经动脉灌注化疗用于经动脉栓塞治疗难治性晚期肝细胞癌的II期试验。
Cancer Chemother Pharmacol. 2008 Apr;61(4):683-8. doi: 10.1007/s00280-007-0523-7. Epub 2007 May 31.
4
[Assessment of therapeutic effects of cisplatin-phosphatidyl-choline-lipiodol (CPL) suspension for hepatocellular carcinoma].
Gan To Kagaku Ryoho. 1991 Aug;18(11):1847-50.
5
[A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].[依托泊苷、表柔比星和顺铂持续肝动脉灌注有效治疗肝细胞癌1例]
Gan To Kagaku Ryoho. 1992 Mar;19(3):383-6.
6
Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.表柔比星-碘油乳剂经导管动脉栓塞治疗肝细胞癌的评估
Cancer Chemother Pharmacol. 1992;31 Suppl:S55-9. doi: 10.1007/BF00687106.
7
Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection.动脉内注射ADMOS单独及ADMOS联合顺铂治疗肝细胞癌的抗癌效果比较。
Cancer Chemother Pharmacol. 1992;31 Suppl:S65-8. doi: 10.1007/BF00687108.
8
[Chemotherapy with Cisplatin-Phosphatidyl-choline-Lipiodol (CPL) suspension in unresectable hepatocellular carcinoma].[顺铂-磷脂酰胆碱-碘油(CPL)混悬液化疗用于不可切除肝细胞癌]
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):3066-9.
9
[Transarterial "pile-up" infusion therapy of cisplatin and lipiodol emulsion in hepatic malignancies without TAE (transcatheter arterial embolization)].经动脉“堆积”输注顺铂与碘油乳剂治疗无TAE(经导管动脉栓塞术)的肝恶性肿瘤
Gan To Kagaku Ryoho. 1992 Mar;19(3):315-21.
10
Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.使用稳定的阿霉素-碘油混悬液评估原发性肝癌的化疗栓塞治疗。
Cancer Chemother Pharmacol. 1992;31 Suppl:S60-4. doi: 10.1007/BF00687107.

引用本文的文献

1
Transcatheter arterial infusion chemotherapy with cisplatin in combination with transcatheter arterial chemoembolization decreases intrahepatic distant recurrence of unresectable hepatocellular carcinoma.顺铂经导管动脉灌注化疗联合经导管动脉化疗栓塞可降低不可切除肝细胞癌的肝内远处复发率。
JGH Open. 2021 May 18;5(6):705-711. doi: 10.1002/jgh3.12573. eCollection 2021 Jun.
2
Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma.顺铂经导管动脉灌注双铂疗法联合米铂经导管动脉化疗栓塞术治疗BCLC - B期肝细胞癌可提高生存率。
Mol Clin Oncol. 2016 Nov;5(5):511-516. doi: 10.3892/mco.2016.998. Epub 2016 Aug 22.
3

本文引用的文献

1
Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.使用油性造影剂进行肿瘤的选择性药物靶向:增强治疗效果和X射线成像。
Cancer Res. 1984 May;44(5):2115-21.
2
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.动脉内注射高分子抗癌剂丝裂霉素与脂质淋巴造影剂联合应用对肝癌的影响:初步报告
Eur J Cancer Clin Oncol. 1983 Aug;19(8):1053-65. doi: 10.1016/0277-5379(83)90028-7.
3
Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma.米铂(MPT)经球囊阻塞肝动脉化疗栓塞术(TACE)治疗肝细胞癌后局部复发的预测因素
PLoS One. 2014 Jul 21;9(7):e103009. doi: 10.1371/journal.pone.0103009. eCollection 2014.
4
Therapeutic effect of a CDDP-epirubicin-Lipiodol emulsion on advanced hepatocellular carcinoma.顺铂-表柔比星-碘油乳剂对晚期肝细胞癌的治疗效果
Cancer Chemother Pharmacol. 1994;33 Suppl:S74-8. doi: 10.1007/BF00686672.
Clin Oncol. 1981 Dec;7(4):275-80.
4
Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.
Radiology. 1985 Jan;154(1):25-9. doi: 10.1148/radiology.154.1.2981114.
5
Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma.使用悬浮于油性淋巴造影剂中的顺铂进行肝动脉注射化疗治疗肝细胞癌。
Cancer. 1989 Oct 15;64(8):1586-94. doi: 10.1002/1097-0142(19891015)64:8<1586::aid-cncr2820640805>3.0.co;2-e.
6
Induction of remission in hepatocellular carcinoma with doxorubicin.阿霉素诱导肝细胞癌缓解
Lancet. 1978 May 13;1(8072):1006-9. doi: 10.1016/s0140-6736(78)90735-3.